Stock Fundamentals

Reality Check - Cipla

Dhuraivel Gunasekaran | Updated on November 11, 2018 Published on November 11, 2018

Cipla needs a booster shot

The stock of pharma major Cipla has declined nearly 18 per cent over the last month. The fall in the share price has been steep, after it registered a poor show (year-on-year) in the recent September. Cipla reported a 11 per cent decline in its consolidated net profit in the second quarter, to ₹377 crore, as against ₹423 crore in the same quarter last year. The consolidated net sales for the quarter were ₹4,012 crore, down 2 per cent from ₹4,082 crore in the same period last year.

Sales from India, which contributed around 41 per cent of Cipla’s overall revenues, remained almost unchanged Y-o-Y at ₹1,644 crore. The company still retains its No 1 position in respiratory, urology and paediatrics.

Sales from North America, which accounts for 19 per cent of the overall sales, grew 25 per cent Y-o-Y, driven by product rationalisation and ramp-up of launches. The company may have to do really well in the second half of this fiscal for markets to view the stock favourably.

Published on November 11, 2018

A letter from the Editor

Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.